financetom
KO
financetom
/
Consumer Staples
/
KO
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
The Coca-Cola CompanyKO
62.55USD
+0.10 (0.16%)
Dec 20, 2024, 4:00 PM - At close
62.59USD
+0.04 (0.06%)
Dec 20, 2024, 6:32 PM EST - Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
269.45B
Revenue (ttm)
46.37B
Net Income (ttm)
10.41B
Shares Out
4.31B
EPS (ttm)
2.41
PE Ratio
25.96
Forward PE
21.48
Dividend
$1.94 (3.10%)
Ex-Dividend Date
Nov 29, 2024
Volume
14,833,294
Open
62.47
Previous Close
62.45
Day's Range
62.29 - 63.06
52-Week Range
57.93 - 73.53
Beta
0.61
Analysts
Strong Buy
Price Target
72.47 (0.0%)
Earnings Date
Feb 11, 2025
Description >

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide.

The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages.

It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores.

The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands.

It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators.

The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Latest News >
Campari has taste for more M&A after Courvoisier deal, new CEO says
Campari has taste for more M&A after Courvoisier deal, new CEO says
May 7, 2024
MILAN, May 7 (Reuters) - Campari will seek further M&A opportunties after completing the buyout of French cognac house Courvoisier, the new head of the Italian drinks group said on Tuesday. The group completed the 1.22-billion euro ($1.3 billion)acquisition of Courvoisier last week, earlier than expected by analysts. It was the largest ever deal for Campari, whose brands include the...
Brazil meatpackers join forces to resume operations amid floods, meat lobby says
Brazil meatpackers join forces to resume operations amid floods, meat lobby says
May 7, 2024
SAO PAULO, May 7 (Reuters) - Competing Brazilian meatpackers have joined forces to circumvent problems caused by heavy flooding in Rio Grande do Sul state, where torrential rains severely disrupted operations, a local meat lobby said on Tuesday. Jose Ribas, who presides over Sindicarne in the neighboring state of Santa Catarina, said local meatpackers were working in partnership to overcome...
Market Chatter: Exxon Mobil to Establish Tech Hub in Houston, Close New Jersey, Ontario Campuses
Market Chatter: Exxon Mobil to Establish Tech Hub in Houston, Close New Jersey, Ontario Campuses
May 7, 2024
12:28 PM EDT, 05/07/2024 (MT Newswires) -- Exxon Mobil ( XOM ) plans to set up a single North American research and technology hub at its Houston headquarters and close campuses in Clinton, New Jersey, and Sarnia in Ontario, Bloomberg reported Tuesday, citing a company spokeswoman. The majority of 700 workers affected by the closures are being offered roles in...
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
May 7, 2024
12:24 PM EDT, 05/07/2024 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) and Agenus ( AGEN ) said Tuesday they have signed a royalty financing agreement to support the clinical development of Agenus' ( AGEN ) botensilimab and balstilimab, including a confirmatory phase 3 trial in metastatic, relapsed or refractory colorectal cancer. Under the terms of the agreement, Ligand will...
Copyright 2023-2024 - www.financetom.com All Rights Reserved